Journals / Türk Onkoloji Dergisi / 2022 / Cilt: 37 - Sayı: 2

Cisplatin and Etoposide with Concurrent Radiotherapy in Locally Advanced Thymic Carcinoma

Pages
223–226
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

USLU, G. H., AKDENİZ, Ç. Y., YEŞILIRMAK, N. (2022). Cisplatin and Etoposide with Concurrent Radiotherapy in Locally Advanced Thymic Carcinoma. Türk Onkoloji Dergisi, Cilt: 37 - Sayı: 2, 223–226. https://ajindex.com/articles/639050

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Shimosato Y, Kameya T, Nagai K, Suemasu K. Squa- mous cell carcinoma of the thymus. An analysis of eight cases. Am J Surg Pathol 1977;1(2):109–21
  2. Venuta F, Rendina EA, Longo F, De Giacomo T, Anile M, Mercadante E, et al. Long-term outcome after mul- timodality treatment for stage III thymic tumors. Ann Thorac Surg 2003;76(6):1866–72; discussion 1872
  3. Bretti S, Berruti A, Loddo C, Sperone P, Casadio C, Tessa M, et al; Piemonte Oncology Network. Multi- modal management of stages III-IVa malignant thy- moma. Lung Cancer 2004;44(1):69–77
  4. Kim ES, Putnam JB, Komaki R, Walsh GL, Ro JY, Shin HJ, et al. Phase II study of a multidisciplinary ap- proach with induction chemotherapy, followed by sur- gical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 2004;44(3):369–79
  5. Morio A, Nakahara K, Ohse Y, Tahara M, Goto T, Yaku- maru K et al. Efficacy of induction chemoradiotherapy in thymic cancer: report of a successful case and re- view of the literature. Int J Clin Oncol 2002;7:201–4
  6. Shintani Y, Ohta M, Hazama K, Miyoshi S, Kagisaki K and Matsuda H: Thymic carcinoma successfully re- sected with superior vena cava after chemoradiother- apy. Jpn J Thorac Cardiovasc Surg 2001;49:717–21
  7. Masaoka A, Monden Y, Nakahara K, Tanioka T. Fol- low-up study of thymomas with special reference to their clinical stages. Cancer 1981;48(11):2485–92
  8. Fornasiero A, Daniele O, Ghiotto C, Piazza M, Fiore-Donati L, Calabró F, et al. Chemotherapy for invasive thymoma. A 13-year experience. Cancer 1991;68(1):30–3
  9. Loehrer PJ Sr, Kim K, Aisner SC, Livingston R, Ein- horn LH, Johnson D, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thy- moma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol 1994;12(6):1164–8
  10. Giaccone G, Ardizzoni A, Kirkpatrick A, Clerico M, Sahmoud T, van Zandwijk N. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the Euro- pean Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol 1996;14(3):814–20
  11. Highley MS, Underhill CR, Parnis FX, Karapetis C, Rankin E, Dussek J, et al. Treatment of invasive thy- moma with single-agent ifosfamide. J Clin Oncol 1999;17(9):2737–44
  12. Grassin F, Paleiron N, André M, Caliandro R, Bretel